Michael Gutch

Director, ALBIREO PHARMA, INC.

Companies

ALBIREO PHARMA, INC.Board member Nov 7, 2016 to Mar 2, 2023¹
Entasis TherapeuticsChief Fin. and Bus. Officer Jan 27, 2020 to Feb 15, 2022²
Entasis TherapeuticsChief financial officer Sep 25, 2018 to Nov 3, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Entasis Therapeutics167,572 shares⁴Jan 18, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 18, 2022Granted 125,000 shares of Entasis Therapeutics⁴
Nov 2, 2021Shares withheld for tax 3,669 shares at $2.94 of Entasis Therapeutics⁵
Oct 19, 2021Sold 3,759 shares at $3.19 of Entasis Therapeutics⁶
Oct 19, 2021Granted 25,000 shares of Entasis Therapeutics⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARALBIREO PHARMA, INC., Board member
2
SEC EDGAREntasis Therapeutics, Chief Fin. and Bus. Officer
3
SEC EDGAREntasis Therapeutics, Chief financial officer
4
SEC EDGAREntasis Therapeutics shares after the filing of Jan 18, 2022
5
SEC EDGARForm 4 filed Nov 3, 2021
6
SEC EDGARForm 4 filed Oct 20, 2021